University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 13 of 17

COMPLETED

Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study

NCT01475747

COMPLETED Phase 2

Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

NCT01259375

COMPLETED Phase 1

Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients

NCT01291069

COMPLETED NA

Immunization Protection in Child Care (IPiCC) Project

NCT01773759

COMPLETED

Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus

NCT01797627

COMPLETED Phase 1

Study of Kuvan Treatment in Adults With GTPCH Deficiency

NCT01425528

COMPLETED NA

Behavioral Treatment for Substance Abuse

NCT01438346

COMPLETED Phase 1

In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm

NCT01405794

COMPLETED

Percutaneous Versus Open Plate Fixation of Diaphyseal Clavicle Fractures

NCT01405703

COMPLETED Phase 2

Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET

NCT01202994

COMPLETED NA

Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease

NCT01350388

COMPLETED

Functional and Radiographic Outcomes After Shoulder Surgery

NCT01405781

COMPLETED Phase 2

A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

NCT01350947

COMPLETED NA

Comparative Effectiveness of Acute Low Back Pain Management

NCT01726803

TERMINATED NA

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

NCT01243333

COMPLETED Phase 1

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

NCT01149408

COMPLETED NA

Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)

NCT01470560

COMPLETED

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus

NCT01480349

COMPLETED

Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement

NCT01496898

COMPLETED NA

Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand

NCT01549925

COMPLETED NA

Brief Cognitive Behavioral Therapy for Military Populations

NCT02038075

COMPLETED

Analysis of Standard Versus Barbed Sutures in Primary Total Knee Arthroplasty.

NCT01320371

COMPLETED NA

Comparative Anti-Reflux Procedures in Neurologically Impaired Children

NCT01307982

COMPLETED Phase 1

In Vivo Assessment of Silver Biomaterial Nano-Toxicity

NCT01243320

COMPLETED

The Natural History of Congenital Trigger Thumbs

NCT01424995

COMPLETED Phase 1

Multi-Tracer PET Assessment of Primary Brain Tumors

NCT00813566

COMPLETED Early Phase 1

Study of Sodium Bicarbonate in Kidney Transplant Recipients

NCT01225796

COMPLETED

Genetic Analysis of Congenital Diaphragmatic Disorders

NCT01243229

TERMINATED Phase 1

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

NCT01149434

COMPLETED

Retrieval and Analysis of Orthopedic Implants at Revision Arthroplasty Surgery

NCT01425021

COMPLETED

Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality

NCT01202981

COMPLETED

DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation

NCT01150214

COMPLETED Phase 1

Pilot Study of the Safety and Efficacy of Oxandrolone in the Prevention and Treatment of Malnutrition in Infants

NCT01048632

COMPLETED NA

Progressive Strength Training in Spinal Muscular Atrophy

NCT01233817

COMPLETED

STAGES Trial: Study of Adiposity, Growth and Endocrine Stages

NCT01460784

COMPLETED

The Parapatellar Approach to Intramedullary Tibial Nailing

NCT01407718

COMPLETED Phase 2

Validating Interventions for Diverse Adolescents

NCT01018654

COMPLETED NA

Combination Ketamine and Propofol vs Propofol for Emergency Department Sedation: A Prospective Randomized Trial

NCT01269307

COMPLETED Phase 3

The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study

NCT01412372

COMPLETED

Inflammatory Cytokine Quantification in Infants

NCT01155830

COMPLETED Phase 1

RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma

NCT01047293

COMPLETED NA

An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death

NCT02112084

COMPLETED

Prediction of Feeding Problems in Prostaglandin-dependent Prematurely Born Infants With Congenital Heart Disease

NCT01126372

COMPLETED NA

Hospice and End-of-life Symptom Monitoring & Support Using an Automated System Designed for Family Caregivers

NCT02112461

COMPLETED

Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome

NCT01405729

TERMINATED Phase 1

Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot

NCT01007695

COMPLETED Phase 2

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

NCT01187901

TERMINATED

Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Inflammatory Syndromes

NCT01106209

COMPLETED

Arthroereisis Versus Lateral Column Lengthening in the Treatment of Planovalgus Feet

NCT02055495

COMPLETED Phase 1

Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure

NCT01106170

← Previous Page 13 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.